Juliet Houghton (@juliethoughton) 's Twitter Profile
Juliet Houghton

@juliethoughton

CEO based in Durban. Passionate about child and adolescent health and eradicating HIV. Opinions my own.

ID: 20300121

linkhttp://www.sahivcs.org calendar_today07-02-2009 08:55:10

546 Tweet

217 Followers

962 Following

Southern African HIV Clinicians Society (SAHCS) (@sahivsoc) 's Twitter Profile Photo

#SAHCSConference2023 We are planning an outstanding event for you - in #CapeTown - there are still a couple of days to take advantage of our attractive Early Bird offer! Register here: sahcsconference.co.za #HealthcareProffesionals #HIV #TB #HIVResearch

#SAHCSConference2023 We are planning an outstanding event for you - in #CapeTown - there are still a couple of days to take advantage of our attractive Early Bird offer! Register here: sahcsconference.co.za #HealthcareProffesionals #HIV #TB #HIVResearch
Southern African HIV Clinicians Society (SAHCS) (@sahivsoc) 's Twitter Profile Photo

Did you miss our CME Webinar on HIV and #dermatology Here’s another opportunity. Join our re-run tomorrow @ 13h00 👉🏽us02web.zoom.us/webinar/regist… learn more on diagnosing and managing dermatological conditions in the context of #HIV #Healthcare Spotlight RHAP Dr Lehlohonolo Makhakhe

Did you miss our CME Webinar on HIV and #dermatology  Here’s another opportunity. Join our re-run tomorrow @ 13h00 👉🏽us02web.zoom.us/webinar/regist… learn more on diagnosing and managing dermatological conditions in the context of #HIV #Healthcare  <a href="/SpotlightNSP/">Spotlight</a> <a href="/RHAPnews/">RHAP</a> <a href="/Wa_Makhakhe/">Dr Lehlohonolo Makhakhe</a>
Peter Staley 🇺🇦 (@peterstaley) 's Twitter Profile Photo

We may have lost the generic Truvada pay-for-delay case against Gilead Sciences, but our discovery process proved we were right that Gilead harmed thousands of people with HIV just to patent hop. nytimes.com/2023/07/22/bus…

Spotlight (@spotlightnsp) 's Twitter Profile Photo

In what is likely one of the largest treatment rollouts in S African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. #IAS2023 Emily Wong, MD Juliet Houghton Linda-Gail Bekker